MLL5/KMT2E anticorps
-
- Antigène Voir toutes MLL5/KMT2E (MLL5) Anticorps
- MLL5/KMT2E (MLL5) (Myeloid/lymphoid Or Mixed-Lineage Leukemia 5 (Trithorax Homolog) (MLL5))
- Reactivité
- Humain, Souris, Rat
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp MLL5/KMT2E est non-conjugé
-
Application
- Immunohistochemistry (IHC), Immunofluorescence (IF)
- Purification
- Affinity purification
- Immunogène
- Recombinant fusion protein of human KMT2E (NP_061152.3).
- Isotype
- IgG
- Top Product
- Discover our top product MLL5 Anticorps primaire
-
-
- Indications d'application
- IHC 1:50-1:200 IF 1:50-1:200
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 1 mg/mL
- Buffer
- PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3
- Agent conservateur
- Sodium azide
- Stock
- -20 °C
- Stockage commentaire
- Store at -20°C. Avoid freeze / thaw cycles.
-
- Antigène
- MLL5/KMT2E (MLL5) (Myeloid/lymphoid Or Mixed-Lineage Leukemia 5 (Trithorax Homolog) (MLL5))
- Autre désignation
- KMT2E (MLL5 Produits)
- Synonymes
- anticorps HDCMC04P, anticorps MLL5, anticorps 1810033J14Rik, anticorps 9530077A04Rik, anticorps D230038D11Rik, anticorps Mll5, anticorps lysine methyltransferase 2E, anticorps lysine (K)-specific methyltransferase 2E, anticorps KMT2E, anticorps Kmt2e
- Sujet
- This gene is a member of the myeloid/lymphoid or mixed-lineage leukemia (MLL) family and encodes a protein with an N-terminal PHD zinc finger and a central SET domain. Overexpression of the protein inhibits cell cycle progression. Alternate transcriptional splice variants have been characterized.
- Poids moléculaire
-
Observed_MW: 100kDa, 140kDa
Calculated_MW: 68kDa/98kDa/131kDa/180-204kDa
- ID gène
- 55904
- UniProt
- Q8IZD2
- Pathways
- Retinoic Acid Receptor Signaling Pathway, L'effet Warburg
-